
By: John Pecman (C.D. Howe Institute)
Antitrust enforcers have said they need to remain vigilant to protect consumers and assist with the recovery during the COVID-19 pandemic and economic downturn. Does the strict enforcement of competition laws stimulate a quick economic recovery, or would a more flexible approach in distressed sectors better serve the economy?
Vigorous antitrust enforcement worldwide protects competition and ensures a dynamic of creative destruction, promoting economically efficient allocation of scarce resources, higher quality products, relentless innovation and lower prices. However, during an economic crisis, markets can face disruptions that may impair efficient adjustments of production and prices, resulting in politically unacceptable distributional outcomes and causing longer-term “scarring” for the economy. In the present circumstances, policymakers must reflect on whether competition is truly vital to manage the impacts of the crisis and create the best environment for economic recovery.
First, we note that, for antitrust enforcement, the 2008 financial crisis was “business as usual”. The 2008 financial crisis differed from the COVID-19 crisis in cause (i.e., liquidity), effects (primarily a financial shock to demand rather than widespread constraints on real activities) and scale (i.e., the size of the economic contraction). Unlike the 2008 crisis, the economic impacts of the pandemic prompted various countries’ competition agencies to loosen their rules…
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas